|
Signs and Symptoms, Respiratory
|
0.020 |
Biomarker
|
group |
BEFREE |
The ATS-DLD-78 C questionnaire was used to investigate the respiratory symptoms of schoolchildren aged 6-12 years (n = 1190) who lived in one of three urban districts or a suburban district of Ulaanbaatar.
|
31775603 |
2019 |
|
ARTERIAL TORTUOSITY SYNDROME
|
0.800 |
Biomarker
|
disease |
BEFREE |
We revise here the current knowledge on ATS and the role of GLUT10 within the compartmentalization of ascorbate in physiological and diseased states.
|
31621376 |
2019 |
|
Acute respiratory failure
|
0.020 |
Biomarker
|
disease |
BEFREE |
The recent ERS/ATS clinical practice guidelines strongly recommend the application of non invasive ventilation (NIV) for patients with acute respiratory failure (ARF) leading to acute or acute-on-chronic respiratory acidosis (pH 7.35) and not for those patients with acute exacerbation of COPD (AECOPD) and hypercapnia who are not acidotic.
|
31591056 |
2020 |
|
Acute exacerbation of chronic obstructive airways disease
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
The recent ERS/ATS clinical practice guidelines strongly recommend the application of non invasive ventilation (NIV) for patients with acute respiratory failure (ARF) leading to acute or acute-on-chronic respiratory acidosis (pH 7.35) and not for those patients with acute exacerbation of COPD (AECOPD) and hypercapnia who are not acidotic.
|
31591056 |
2020 |
|
Usual Interstitial Pneumonia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Ground glass opacities, traction bronchiolectasis and reticulations, a "Probable UIP Pattern" by ATS criteria progressed to UIP in 47% of patients on follow-up imaging.
|
31326632 |
2020 |
|
Community acquired pneumonia
|
0.020 |
Biomarker
|
disease |
BEFREE |
Erratum: Modified IDSA/ATS minor criteria for severe community-acquired pneumonia best predicted mortality: Erratum.
|
31305697 |
2017 |
|
ARTERIAL TORTUOSITY SYNDROME
|
0.800 |
Biomarker
|
disease |
BEFREE |
Virtual screening expands this possibility to explore more compounds that can interact with GLUT10 and may aid in understanding the mechanisms leading to ATS.
|
31203799 |
2020 |
|
Pneumonia, Ventilator-Associated
|
0.010 |
Biomarker
|
disease |
BEFREE |
Based on a meta-analysis of nine studies (RR 1.29; 95% CI 1.13-1.47), the 2016 IDSA/ATS Hospital-acquired Pneumonia Guideline Committee recommended that adjunctive IA be used to treat VAP due to Gram-negative bacilli that are susceptible to only aminoglycosides or polymyxins.
|
31035015 |
2019 |
|
Asthma
|
0.040 |
Biomarker
|
disease |
BEFREE |
Fourteen subjects with severe asthma were recruited in this study according to the criteria of ATS severe asthma definition.
|
30961946 |
2019 |
|
Adenocarcinoma of lung (disorder)
|
0.100 |
Biomarker
|
disease |
BEFREE |
Pubmed and Cochrane databases were searched from January 2011 to June 2018 for studies that included patients with LAC who underwent surgical resection were classified according to the new IASLC/ATS/ERS classification.
|
30833014 |
2019 |
|
Asthma
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Severe asthma was defined according to three internationally well-known criteria: the ATS workshop definition from 2000 used in the US Severe Asthma Research Programme (SARP), the 2014 ATS/ERS Task force definition and the GINA 2017.
|
30817038 |
2019 |
|
ARTERIAL TORTUOSITY SYNDROME
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Transport of dehydroascorbic acid is impaired in the endomembranes of fibroblasts from arterial tortuosity syndrome (ATS) patients, due to the mutation in the gene coding for glucose transporter GLUT10.
|
30800210 |
2019 |
|
Lung Diseases, Obstructive
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Abbreviations: CS: cross-sectional; CC: case-control; NR: not reported; ATS: American Thoracic Society; BMRC: British Medical Research Council; GOLD: Global Initiative for Obstructive Lung Disease; IAP: indoor air pollution; BMF: biomass fuel; CB: chronic bronchitis; OR: odds ratio; UCI; upper confidence interval; LCI: lower confidence interval; COPD: chronic obstructive pulmonary disease.
|
30754998 |
2020 |
|
Community acquired pneumonia
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Infectious Disease Society of America/American Thoracic Society (IDSA/ATS) minor criteria for severe community-acquired pneumonia (CAP) are of unequal weight in predicting mortality, but the major problem associated with IDSA/ATS minor criteria might be a lack of consideration of weight in prediction in clinical practice.
|
30704469 |
2019 |
|
CATARACT, ANTERIOR POLAR
|
0.020 |
Biomarker
|
disease |
BEFREE |
Scored minor criteria orchestrated improvements in predicting mortality and severity in patients with CAP, and scored minor criteria of ≥2 scores or the presence of 2 or more IDSA/ATS minor criteria might be more valuable cut-off value for severe CAP, which might have implications for more accurate clinical triage decisions.
|
30704469 |
2019 |
|
Pneumonia
|
0.010 |
Biomarker
|
disease |
BEFREE |
The mortality rates, and sequential organ failure assessment (SOFA) and pneumonia severity index (PSI) scores increased significantly with the numbers of IDSA/ATS minor criteria present and minor criteria scores.
|
30704469 |
2019 |
|
Adenocarcinoma of lung (disorder)
|
0.100 |
Biomarker
|
disease |
BEFREE |
Molecular signatures in IASLC/ATS/ERS classified growth patterns of lung adenocarcinoma.
|
30352093 |
2018 |
|
Signs and Symptoms, Respiratory
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Two definitions were used: (i) "doctor diagnosed asthma" when the respondent reported that he/she had ever been diagnosed with BA by a doctor, (ii) "wheezing symptoms" (when the respondent reported wheezing at the ATS Respiratory Symptoms Questionnaire during the study) using GINA (2012) recommendations.
|
29976177 |
2018 |
|
Wheezing
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Two definitions were used: (i) "doctor diagnosed asthma" when the respondent reported that he/she had ever been diagnosed with BA by a doctor, (ii) "wheezing symptoms" (when the respondent reported wheezing at the ATS Respiratory Symptoms Questionnaire during the study) using GINA (2012) recommendations.
|
29976177 |
2018 |
|
Adenocarcinoma of lung (disorder)
|
0.100 |
Biomarker
|
disease |
BEFREE |
Correlation between EML4-ALK, EGFR and clinicopathological features based on IASLC/ATS/ERS classification of lung adenocarcinoma.
|
29952952 |
2018 |
|
Malignant neoplasm of lung
|
0.070 |
Biomarker
|
disease |
BEFREE |
To investigate the correlation between echinodermmicro tubule associated protein-like 4 (EML4)-anaplasticlymphomakinase (ALK), epidermal growth factor receptor (EGFR) and clinicopathological features in patients diagnosed with lung adenocarcinoma according to International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) international multidisciplinary classification of lung adenocarcinoma.Ninety patients diagnosed with lung adenocarcinoma underwent surgical pathological classification.
|
29952952 |
2018 |
|
Carcinoma of lung
|
0.060 |
Biomarker
|
disease |
BEFREE |
To investigate the correlation between echinodermmicro tubule associated protein-like 4 (EML4)-anaplasticlymphomakinase (ALK), epidermal growth factor receptor (EGFR) and clinicopathological features in patients diagnosed with lung adenocarcinoma according to International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) international multidisciplinary classification of lung adenocarcinoma.Ninety patients diagnosed with lung adenocarcinoma underwent surgical pathological classification.
|
29952952 |
2018 |
|
Primary malignant neoplasm of lung
|
0.060 |
Biomarker
|
disease |
BEFREE |
To investigate the correlation between echinodermmicro tubule associated protein-like 4 (EML4)-anaplasticlymphomakinase (ALK), epidermal growth factor receptor (EGFR) and clinicopathological features in patients diagnosed with lung adenocarcinoma according to International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) international multidisciplinary classification of lung adenocarcinoma.Ninety patients diagnosed with lung adenocarcinoma underwent surgical pathological classification.
|
29952952 |
2018 |
|
Obstructive ventilatory defect
|
0.010 |
Biomarker
|
disease |
BEFREE |
In 2014, a new alternative classification (GLI classification) for grading the OVD severity was proposed to replace the 2005-ATS/ERS one.
|
29927708 |
2018 |
|
Cortisol Measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Susceptibility to corticosteroid-induced adrenal suppression: a genome-wide association study.
|
29551627 |
2018 |